The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11017 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults.. JAMA. 319(19), 2041.
Anagnostis, P., Theocharis P., Lallas K., Konstantis G., Mastrogiannis K., Bosdou J. K., et al. (2020).  Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis.. Maturitas. 135, 74-79.
Anagnostis, P., Bosdou J. K., Vaitsi K., Goulis D. G., & Lambrinoudaki I. (2020).  Estrogen and bones after menopause: a reappraisal of data and future perspectives.. Hormones (Athens).
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Panagiotou A., & Kita M. (2011).  Non-functioning pituitary adenomas: a single center experience.. Exp Clin Endocrinol Diabetes. 119(5), 314-9.
Anagnostis, P., Pliakos I., Panidis S., Chorti A., Stelmach V., Michalopoulos A., et al. (2019).  Should total thyroidectomies be performed by high-volume endocrine surgeons? A cost-effectiveness analysis.. Endocrine.
Anagnostis, P., Paschou S. A., Gonzalez-Rodriguez E., Potoupnis M., Tsiridis E., Lamy O., et al. (2019).  Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases.. J Clin Rheumatol.
Anagnostis, P., Karras S., Paschou S. A., & Goulis D. G. (2015).  Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk.. Blood Coagul Fibrinolysis. 26(6), 599-603.
Anagnostis, P., Gkekas N. K., Achilla C., Pananastasiou G., Taouxidou P., Mitsiou M., et al. (2020).  Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis.. Calcif Tissue Int. 107(5), 453-463.
Anagnostis, P., Efstathiadou Z. A., Polyzos S. A., Adamidou F., Slavakis A., Sapranidis M., et al. (2011).  Acromegaly: presentation, morbidity and treatment outcomes at a single centre.. Int J Clin Pract. 65(8), 896-902.
Anagnostis, P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., & Goulis D. G. (2019).  Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?. Curr Vasc Pharmacol. 17(6), 564-572.
Anagnostis, P., Paparodis R. D., Bosdou J. K., Bothou C., Macut D., Goulis D. G., et al. (2021).  Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.. Endocrine. 74(2), 245-253.
Anagnostis, P., Vakalopoulou S., Vyzantiadis T-A., Charizopoulou M., Karras S., Goulis D. G., et al. (2014).  The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B.. Haemophilia. 20(2), 268-75.
Anagnostis, P., Dimopoulou C., Karras S., Lambrinoudaki I., & Goulis D. G. (2015).  Sarcopenia in post-menopausal women: Is there any role for vitamin D?. Maturitas. 82(1), 56-64.
Anagnostis, P., Goulis D. G., & Mikhailidis D. P. (2020).  Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives.. Curr Pharm Des. 26(43), 5547-5550.
Anagnostis, P., Vaitsi K., Veneti S., Georgiou T., Paschou S. A., Lambrinoudaki I., et al. (2019).  Management of dyslipidaemias in the elderly population-A narrative review.. Maturitas. 124, 93-99.
Anagnostis, P., Vakalopoulou S., Charizopoulou M., Karras S., & Garipidou V. (2013).  Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity.. Haemophilia. 19(5), e308-10.
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Karathanassi E., & Kita M. (2012).  Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.. Pituitary. 15(1), 25-9.
Anagnostis, P., Vyzantiadis T-A., Charizopoulou M., Adamidou F., Karras S., Goulis D. G., et al. (2013).  The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.. Thromb Haemost. 110(2), 257-63.
Anagnostis, P., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".. J Clin Endocrinol Metab. 105(1), 
Anagnostis, P., Karras S. N., & Goulis D. G. (2015).  Bone disease in patients with haemophilia A and B--where are we now?. Haemophilia. 21(1), 1-3.
Anagnostis, P., Lambrinoudaki I., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2019).  Drug holidays in osteoporosis treatment: mind the gaps!. Osteoporos Int. 30(12), 2523-2524.
Anagnostis, P., Vakalopoulou S., Christoulas D., Paschou S. A., Papatheodorou A., Garipidou V., et al. (2018).  The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.. Haemophilia. 24(2), 316-322.
Anagnostis, P., Katsiki N., Athyros V. G., & Karagiannis A. (2014).  Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay.. Angiology.
Anagnostis, P., Selalmatzidou D., Sapranidis M., Panagiotou A., Polyzos S. A., Slavakis A., et al. (2012).  Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study.. Indian J Endocrinol Metab. 16(1), 146-7.
Anagnostis, P., Florentin M., Livadas S., Lambrinoudaki I., & Goulis D. G. (2022).  Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.. Int J Mol Sci. 23(3), 

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.